Literature DB >> 10399353

Database of biologically active peptide sequences.

J Dziuba1, P Minkiewicz, D Nałecz, A Iwaniak.   

Abstract

Proteins are sources of many peptides with diverse biological activity. Such peptides are considered as valuable components of foods with desired and designed biological activity. Two strategies are currently recommended for research in the area of biological activity of food protein fragments. The first strategy covers investigations on products of enzymic hydrolysis of proteins. The second one is synthesis of peptides identical with protein fragments and investigations using these peptides. It is possible to predict biological activity of protein fragments using sequence alignments between proteins and biologically active peptides from database. Our database contains currently 527 sequences of bioactive peptides with antihypertensive, opioid, immunomodulating and other activities. The sequence alignments can give information about localization of biologically active fragments in protein chain, but not about possibilities of enzymic release of such fragments. The information is thus equivalent with this obtained using synthetic peptides identical with protein fragments. Possibilities offered by the database are discussed using wheat alpha/beta-gliadin, bovine beta-lactoglobulin and bovine beta-casein (including influence of genetic polymorphism and genetic engineering on amino acid sequences) as examples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10399353     DOI: 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.0.CO;2-A

Source DB:  PubMed          Journal:  Nahrung        ISSN: 0027-769X


  16 in total

Review 1.  Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.

Authors:  Simone Marcone; Orina Belton; Desmond J Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  2016-06-17       Impact factor: 4.335

2.  Phenotype analysis of mice deficient in the peptide transporter PEPT2 in response to alterations in dietary protein intake.

Authors:  Isabelle M Frey; Isabel Rubio-Aliaga; Martina Klempt; Eckhard Wolf; Hannelore Daniel
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

3.  Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides.

Authors:  David C Dallas; Andres Guerrero; Nora Khaldi; Patricia A Castillo; William F Martin; Jennifer T Smilowitz; Charles L Bevins; Daniela Barile; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

4.  Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.

Authors:  M Hayes; C Stanton; H Slattery; O O'Sullivan; C Hill; G F Fitzgerald; R P Ross
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

5.  Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026.

Authors:  M Hayes; R P Ross; G F Fitzgerald; C Hill; C Stanton
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

6.  Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species.

Authors:  F Minervini; F Algaron; C G Rizzello; P F Fox; V Monnet; M Gobbetti
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

7.  Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity.

Authors:  Catherine Mooney; Niall J Haslam; Gianluca Pollastri; Denis C Shields
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Modeling the QSAR of ACE-Inhibitory Peptides with ANN and Its Applied Illustration.

Authors:  Ronghai He; Haile Ma; Weirui Zhao; Wenjuan Qu; Jiewen Zhao; Lin Luo; Wenxue Zhu
Journal:  Int J Pept       Date:  2011-06-09

9.  Gastrointestinal endogenous proteins as a source of bioactive peptides--an in silico study.

Authors:  Lakshmi A Dave; Carlos A Montoya; Shane M Rutherfurd; Paul J Moughan
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

10.  The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes.

Authors:  Chia-Ling Jao; Chuan-Chuan Hung; Yu-Shan Tung; Pei-Yi Lin; Meng-Chun Chen; Kuo-Chiang Hsu
Journal:  Biomedicine (Taipei)       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.